Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Seeger

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group studyC A Perez, K K Matthay, J B Atkinson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group resultsK K Matthay, M C O'Leary, N K Ramsay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastomaG M Brodeur, R C Seeger, A Barrett, et al.
Progress in Clinical and Biological Research|January 1, 1988
International criteria for diagnosis, staging and response to treatment in patients with neuroblastomaG M Brodeur, R C Seeger, A Barrett, et al.
Cancer Gene Therapy|September 1, 1995
Sustained cytokine production and immunophenotypic changes in human neuroblastoma cell lines transduced with a human gamma interferon vectorK Uçar, R C Seeger, P M Challita, et al.
Progress in Clinical and Biological Research|January 1, 1994
Comparison of autologous and allogeneic bone marrow transplantation for neuroblastomaK K Matthay, R C Seeger, C P Reynolds, et al.
The Journal of Clinical Investigation|July 1, 1991
High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplificationN Hailat, D R Keim, R F Melhem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group studyM L Schmidt, J N Lukens, R C Seeger, et al.
Medical and Pediatric Oncology|July 24, 2001
Allelic deletion at chromosome bands 11q14-23 is common in neuroblastomaJ M Maris, C Guo, P S White, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group studyH J Nickerson, K K Matthay, R C Seeger, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group studyC A Perez, K K Matthay, J B Atkinson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group resultsK K Matthay, M C O'Leary, N K Ramsay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastomaG M Brodeur, R C Seeger, A Barrett, et al.
Progress in Clinical and Biological Research|January 1, 1988
International criteria for diagnosis, staging and response to treatment in patients with neuroblastomaG M Brodeur, R C Seeger, A Barrett, et al.
Cancer Gene Therapy|September 1, 1995
Sustained cytokine production and immunophenotypic changes in human neuroblastoma cell lines transduced with a human gamma interferon vectorK Uçar, R C Seeger, P M Challita, et al.
Progress in Clinical and Biological Research|January 1, 1994
Comparison of autologous and allogeneic bone marrow transplantation for neuroblastomaK K Matthay, R C Seeger, C P Reynolds, et al.
The Journal of Clinical Investigation|July 1, 1991
High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplificationN Hailat, D R Keim, R F Melhem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group studyM L Schmidt, J N Lukens, R C Seeger, et al.
Medical and Pediatric Oncology|July 24, 2001
Allelic deletion at chromosome bands 11q14-23 is common in neuroblastomaJ M Maris, C Guo, P S White, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group studyH J Nickerson, K K Matthay, R C Seeger, et al.
Pageof 16